Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Singapore General Hospital
Information provided by (Responsible Party):
Singapore General Hospital Identifier:
First received: May 15, 2012
Last updated: November 26, 2014
Last verified: November 2014

The purpose of this study is to generate a prospective database of all patients evaluated for diffuse parenchymal lung diseases to provide much needed data on the various disease aetiologies, incidence and prevalence rates, clinical and radiological presentations, pathologic correlations, disease progression and response to treatment, and final outcomes in this group of patients in Singapore.

Diffuse Parenchymal Lung Diseases

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Prospective Data Collection of Clinical, Pulmonary Function, Radiological, Bronchoscopic and Fibered Confocal Fluorescence Microscopy Imaging, and Pathological Characteristics in Patients With Diffuse Parenchymal Lung Diseases

Resource links provided by NLM:

Further study details as provided by Singapore General Hospital:

Primary Outcome Measures:
  • Final diagnoses of patients presenting with diffuse parenchymal lung disease after complete evaluation [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: May 2012
Estimated Study Completion Date: April 2022
Estimated Primary Completion Date: April 2022 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   21 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients evaluated for diffuse parenchymal lung diseases


Inclusion Criteria:

  • All patients 21 years old and older diagnosed with suspected diffuse parenchymal lung disease (multi-lobar pulmonary infiltrates)

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01600378

Contact: Su Ying Low, BMBCh +65 63214700

Singapore General Hospital Recruiting
Singapore, Singapore, 169608
Contact: Su Ying Low, BMBCh    +65 3214700   
Principal Investigator: Su Ying Low, BMBCh         
Sponsors and Collaborators
Singapore General Hospital
Principal Investigator: Su Ying Low, BMBCh Singapore General Hospital
  More Information

Responsible Party: Singapore General Hospital Identifier: NCT01600378     History of Changes
Other Study ID Numbers: 2012/245/Cilddatabase
Study First Received: May 15, 2012
Last Updated: November 26, 2014
Health Authority: Singapore: Domain Specific Review Boards

Keywords provided by Singapore General Hospital:
diffuse parenchymal lung disease
interstitial lung disease
idiopathic pulmonary fibrosis

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases processed this record on February 27, 2015